Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Plasma exchange and concomitant therapy in TTP.

D Stoffner, F C Banthien, R Habersetzer

    The International Journal of Artificial Organs
    |July 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Adjuvant chemotherapy of stage-ii nonseminomatous testicular cancer.

    Oncology reports·2011
    Same author

    Acute postinfectious glomerulonephritis associated with Campylobacter jejuni enteritis - a case report and review of the literature on C. jejuni's potential to trigger immunologically mediated renal disease.

    Clinical nephrology·2010
    Same author

    Fibrillary glomerulonephritis mimicking membranous nephropathy--a diagnostic pitfall.

    Pathology, research and practice·2009
    Same author

    Parallel occurrence of Erdheim-Chester disease and eosinophilic granuloma in the same patient.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2008
    Same author

    [Orellanus syndrome: a rare cause of acute renal failure].

    Deutsche medizinische Wochenschrift (1946)·2007
    Same author

    [Nephrogenic systemic fibrosis].

    Der Radiologe·2007

    Plasma exchange has dramatically improved survival for thrombotic thrombocytopenic purpura (TTP). Optimal TTP therapy involves daily plasma exchange with fresh frozen plasma, antiplatelet agents, and steroids, with other treatments reserved for refractory cases.

    Area of Science:

    • Hematology
    • Internal Medicine
    • Critical Care Medicine

    Background:

    • Thrombotic thrombocytopenic purpura (TTP) management has evolved significantly since the introduction of plasma exchange in 1977.
    • Despite improved survival rates, optimal therapeutic strategies for TTP remain debated, with numerous case reports lacking consensus.

    Observation:

    • This review analyzes 4 TTP episodes in 3 patients, detailing treatment approaches and outcomes.
    • Initial treatment involved intensive fresh frozen plasma (FFP) exchange, antiplatelet agents, and corticosteroids.
    • One patient required cytotoxic therapy (vincristine) and splenectomy for refractory disease.

    Findings:

    • A remission rate of 75% was achieved with the initial intensive FFP exchange protocol, highlighting the need for individualized treatment regimens.

    Related Experiment Videos

  • Variable responses suggest TTP may encompass diverse underlying pathologies rather than a single disease entity.
  • Daily plasma exchange with FFP, antiplatelet agents, and steroids is identified as the most effective current therapy.

    • Implications:

    • The findings support a standardized initial treatment protocol for TTP while acknowledging the necessity for tailored therapeutic adjustments.
    • Further research into the heterogeneous nature of TTP is warranted to refine treatment strategies.
    • Vincristine and splenectomy are recommended as salvage therapies for TTP cases unresponsive to the primary protocol.